Skip to content
OnyxPrime

Zimbabwe Declines ‘Unbalanced’ American Health Aid Deal Over Data Concerns

Health funding image
The proposed American financial assistance would have supported initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has turned down a substantial American health deal worth $367m (£272m) spanning five years due to Washington's request for confidential data.

This move came to light following a government memo from December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".

A government spokesperson later explained that the US was seeking health data for scientific study and commercial purposes while was unwilling to share the benefits from any future medical innovations.

"We must now begin the challenging and unfortunate process of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the US had furnished more than $1.9bn for health programmes to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has appealed for further talks to secure a agreement acceptable to both sides so the nation's critical HIV programme can continue.

Broader Background

Zimbabwe's decision follows a comparable case in Kenya, where a high court suspended a related deal with the US after legal challenges were raised about the safety of Kenyans' health data.

Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

The agency had overseen assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was pursuing government-to-government deals to enhance transparency and accountability.

As per reports, 16 nations in Africa have so far signed these new health pacts, constituting more than $18.3bn in committed funds.

Specifics of the Rejected Deal

This assistance for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We are confident this cooperation might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment through US-supported programmes," the Ambassador added.

However, official spokesman Nick Mangwana maintained the arrangement was "unequal".

"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, with no corresponding guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that might result from that provided information," his statement read.

"In essence, our nation would supply the raw materials for scientific discovery without any assurance that the resulting innovations would be available to our people if a new health crisis emerge."

Sovereignty and Global Health

He also noted that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were upending frameworks previously established through the international health agency.

The spokesperson cited its Pandemic Benefit-Sharing system created to manage future pandemics.

"This framework is designed to ensure that when a country provides its information, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to create them."

The government's concerns over the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We are open to further dialogue with our US partners on how future co-operation could be structured in a manner that honours the sovereignty and dignity of each country."

Medical Community Response

A leading public health body said it recognised the government's concerns, but urged that talks must proceed since much of the country's Aids initiatives were funded by external financing.

"If technical issues arise, such as those involving data governance or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," it said.

This impasse highlights the ongoing tensions between accepting much-needed international aid and safeguarding a country's data in an increasingly interconnected world.

AC
The writer

Amy Cameron

A tech journalist with over a decade of experience covering consumer electronics and emerging technologies across Europe.

OnyxPrime

Type to search articles.